MedPath

Effect of Iranian traditional medicine-based diet on Non-alcoholic fatty liver(NAFLD)

Not Applicable
Conditions
on alcoholic fatty liver(NAFLD).
Fatty (change of) liver, not elsewhere classified
Registration Number
IRCT2014081518807N1
Lead Sponsor
Vice chancellor for research of Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

age 20 to 60 years? the detection of Non-alcoholic fatty liver(NAFLD)by Ultrasound Images (grade 1 or 2 or 3 ). Exclusion criteria: diabetes; heart disease; hypertension; over weight(BMI greater than 30 ). familial hyperlipidemia; active alcohol or addiction; discourage patients from continuing to participate in the plan; Breastfeeding; Pregnancy; Any other chronic diseases such as kidney stones, gallstones, cardiovascular surgery; abdominal surgery; CVA; acute hepatitis; acute Pancreatitis; major Surgery during the last 6 months and also any surgery on the liver and gallbladder. Rapid weight loss during the last 3 months for any reason. Drop Out Criteria: Any medication side effects during treatment; Other acute illnesses during the study period who had liver adverse impact on yield: Such as gallstones and surgery and general anesthesia and drugs with liver toxicity;
Increase in liver enzymes (AST, ALT) and Fasting blood sugar (FBS) during the study period; Consent to continue participating in the study; Alcohol and alcoholic beverages during the study period; Drug use is incorrect; Failure to follow the prescribed diet; Not see the patient during follow up; pregnancy and breastfeeding women participating in the project.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measure levels of liver enzymes (AST , ALT). Timepoint: Before the intervention; 6 weeks after the intervention;End of the intervention (3 months). Method of measurement: Autoanalyzer.
Secondary Outcome Measures
NameTimeMethod
ltrasound Images of liver;Fatty tissue infiltration in liver (grade 1 or 2 or 3 ). Timepoint: Before the intervention;6 weeks after the intervention ;End of the intervention (3 months). Method of measurement: The grading of fatty liver infiltration of fat tissue based on ultrasound by one radiologist.;Body mass index (BMI). Timepoint: Before the intervention;6 weeks after the intervention ;End of the intervention (3 months). Method of measurement: Weight and height measurements by one person in the same center.
© Copyright 2025. All Rights Reserved by MedPath